Pancreatic Cancer Research

ResearcherDalian Medical UniversityActive in the last 2 years

Henan Qin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2989-7424; OpenAlex author ID A5001341362. Sources: OpenAlex.

Their work

Papers
7 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2022: 2 papers · 2023: 2 papers · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 7

  1. Prognostic and Diagnostic Value of Serum Bile Acid Profiles in Pancreatic Cancer: a Retrospective Multicenter Cohort Study. First author DOI 10.1007/s12029-025-01283-z↗
  2. The TRIB1-PPARγ Axis Regulates Cholesterol Metabolism in Pancreatic Ductal Adenocarcinoma. First author DOI 10.1111/nyas.70224↗
  3. USP10 activates the FAK pathway by stabilizing RIOK3 in pancreatic ductal adenocarcinoma Co-author DOI 10.21203/rs.3.rs-3941004/v1↗
  4. Ubiquitin-Specific Protease 43 Impacts Pancreatic Ductal Adenocarcinoma Prognosis by Altering Its Proliferation and Infiltration of Surrounding Immune Cells. Co-author DOI 10.1155/2023/4311388↗
  5. RIOK3 promotes mTORC1 activation by facilitating SLC7A2-mediated arginine uptake in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/aging.204528↗
  6. RIOK3 promotes pancreatic ductal adenocarcinoma cell invasion and metastasis by stabilizing FAK. Co-author DOI 10.1016/j.heliyon.2022.e10116↗
  7. Tissue metabolomics identified new biomarkers for the diagnosis and prognosis prediction of pancreatic cancer. First author DOI 10.3389/fonc.2022.991051↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhen Ning · 4 shared papers, 2022–2026 · strength 0.85
  2. Mengyuan Xu · 3 shared papers, 2022–2026 · strength 0.66
  3. Peiyuan Yin · 3 shared papers, 2022–2026 · strength 0.65
  4. Jiwei Liu · 3 shared papers, 2022–2024 · strength 0.52
  5. Aman Wang · 3 shared papers, 2022–2023 · strength 0.50
  6. Chaoying Liu · 1 shared paper, 2026 · strength 0.32
  7. A M Wang · 1 shared paper, 2026 · strength 0.30
  8. Rui Sun · 1 shared paper, 2026 · strength 0.30
  9. Shuang Li · 1 shared paper, 2024 · strength 0.19
  10. Rui Sun · 1 shared paper, 2024 · strength 0.19
  11. Ziqi Zhao · 1 shared paper, 2023 · strength 0.18
  12. Guang Tan · 1 shared paper, 2023 · strength 0.18
  13. Chang Liu · 1 shared paper, 2022 · strength 0.15
  14. Haihua Liu · 1 shared paper, 2022 · strength 0.15
  15. Dong Shang · 1 shared paper, 2022 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.